Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Whitney Goldner to Cell Line, Tumor

This is a "connection" page, showing publications Whitney Goldner has written about Cell Line, Tumor.

 
Connection Strength
 
 
 
0.104
 
  1. Bennett RG, Wakeley SE, Hamel FG, High RR, Korch C, Goldner WS. Gene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines. Oncology. 2012; 83(5):264-72.
    View in: PubMed
    Score: 0.052
  2. Kotwal A, Simpson R, Whiteman N, Swanson B, Yuil-Valdes A, Fitch M, Nguyen J, Elhag S, Shats O, Goldner W, Bennett R. Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans. Biochem Pharmacol. 2024 07; 225:116323.
    View in: PubMed
    Score: 0.030
  3. Patel A, Kosmacek EA, Fisher KW, Goldner W, Oberley-Deegan RE. MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer. Radiat Environ Biophys. 2020 03; 59(1):99-109.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)